Artificial intelligence in microbial natural product drug discovery: Current and emerging role Review


Authors: Sahayasheela, V. J.; Lankadasari, M. B.; Dan, V. M.; Dastager, S. G.; Pandian, G. N.; Sugiyama, H.
Review Title: Artificial intelligence in microbial natural product drug discovery: Current and emerging role
Abstract: Covering: up to the end of 2022Microorganisms are exceptional sources of a wide array of unique natural products and play a significant role in drug discovery. During the golden era, several life-saving antibiotics and anticancer agents were isolated from microbes; moreover, they are still widely used. However, difficulties in the isolation methods and repeated discoveries of the same molecules have caused a setback in the past. Artificial intelligence (AI) has had a profound impact on various research fields, and its application allows the effective performance of data analyses and predictions. With the advances in omics, it is possible to obtain a wealth of information for the identification, isolation, and target prediction of secondary metabolites. In this review, we discuss drug discovery based on natural products from microorganisms with the help of AI and machine learning.
Keywords: antineoplastic agents; antineoplastic agent; metabolism; drug discovery; drug development; artificial intelligence; biological product; biological products; procedures; machine learning
Journal Title: Natural Product Reports
Volume: 39
Issue: 12
ISSN: 0265-0568
Publisher: Royal Society of Chemistry  
Date Published: 2022-12-01
Start Page: 2215
End Page: 2230
Language: English
DOI: 10.1039/d2np00035k
PUBMED: 36017693
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 3 January 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors